Yixintang Pharmaceutical Group Co., Ltd.

XSEC:002727 Stock Report

Market Cap: CN¥8.2b

Yixintang Pharmaceutical Group Management

Management criteria checks 4/4

Yixintang Pharmaceutical Group's CEO is Hong Xian Ruan, appointed in Dec 2013, has a tenure of 11.08 years. directly owns 31.03% of the company’s shares, worth CN¥2.54B. The average tenure of the management team and the board of directors is 5.1 years and 5.1 years respectively.

Key information

Hong Xian Ruan

Chief executive officer

CN¥1.0m

Total compensation

CEO salary percentagen/a
CEO tenure11yrs
CEO ownership31.0%
Management average tenure5.1yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO

Hong Xian Ruan (58 yo)

11yrs

Tenure

CN¥1,000,000

Compensation

Mr. Hong Xian Ruan has been President and Non-Independent Director at Yixintang Pharmaceutical Group Co., Ltd. (formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd.) since December 02, 201...

Leadership Team

NamePositionTenureCompensationOwnership
Hong Xian Ruan
President & Executive Chairman11yrsCN¥1.00m31.03%
CN¥ 2.5b
Donglei Xiao
Financial Managerno dataCN¥35.00k0.011%
CN¥ 905.3k
Yong Zhang
Executive President & Executive Director5.1yrsCN¥860.00k0.054%
CN¥ 4.4m
Guowei Ruan
Executive Director5.1yrsCN¥860.00k0.050%
CN¥ 4.1m
Zheng Hong Li
VP & Secretary5.1yrsCN¥500.00k0.033%
CN¥ 2.7m

5.1yrs

Average Tenure

46yo

Average Age

Experienced Management: 002727's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hong Xian Ruan
President & Executive Chairman11.1yrsCN¥1.00m31.03%
CN¥ 2.5b
Yong Zhang
Executive President & Executive Director5.1yrsCN¥860.00k0.054%
CN¥ 4.4m
Guowei Ruan
Executive Director5.1yrsCN¥860.00k0.050%
CN¥ 4.1m
Qiong Liu
Non-Independent Director11.1yrsCN¥100.80k11.49%
CN¥ 941.7m
Chunli Guo
Non-Independent Director8.1yrsCN¥860.00k0.050%
CN¥ 4.1m
Xiaohai Long
Independent Director5.1yrsCN¥120.00kno data
Sitang Duan
Non-Employee Supervisor5.1yrsno datano data
Xudong Chen
Independent Director5.1yrsCN¥120.00kno data
Keyi Xu
Non-Independent Director6.6yrsno datano data
Xianming Yang
Independent Director5.1yrsCN¥120.00kno data
Ping Feng
Chairman of the Supervisory Board5.1yrsno datano data
Wei Zhang
Supervisor5.1yrsno datano data

5.1yrs

Average Tenure

55yo

Average Age

Experienced Board: 002727's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:40
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yixintang Pharmaceutical Group Co., Ltd. is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Haigang ChenChina International Capital Corporation Limited
Feifei XuChina Merchants Securities Co. Ltd.
Bing ZhaoChina Renaissance Securities